Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, …
Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $2.08M and sold $150.05M worth of Hims & Hers Health, Inc. stock.
On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $2.25M and sold $69.24M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Payne Christopher D (director) — $3.9M. Manuel Anja (director) — $132,260.
The last purchase of 1,000 shares for transaction amount of $24,500 was made by Manuel Anja (director) on 2024‑11‑14.
2024-12-17 | Sale | Chief Commercial Officer | 25,550 0.0124% | $32.20 | $822,710 | -15.81% | ||
2024-12-17 | Sale | Chief Executive Officer | 79,246 0.0383% | $32.09 | $2.54M | -15.81% | ||
2024-12-17 | Sale | PAO | 10,012 0.0049% | $32.20 | $322,386 | -15.81% | ||
2024-12-16 | Sale | Chief Executive Officer | 125,661 0.0566% | $29.45 | $3.7M | -8.29% | ||
2024-12-16 | Sale | PAO | 472 0.0002% | $29.58 | $13,962 | -8.29% | ||
2024-12-10 | Sale | Chief Operating Officer | 85,561 0.0411% | $31.01 | $2.65M | -2.36% | ||
2024-12-10 | Sale | Chief Commercial Officer | 7,259 0.0036% | $32.25 | $234,103 | -2.36% | ||
2024-12-02 | Sale | Chief Commercial Officer | 2,054 0.001% | $33.56 | $68,932 | +1.09% | ||
2024-12-02 | Sale | Chief Executive Officer | 33,513 0.0169% | $33.38 | $1.12M | +1.09% | ||
2024-11-26 | Sale | Chief Legal Officer | 2,343 0.0011% | $29.90 | $70,056 | +1.43% | ||
2024-11-25 | Sale | Chief Commercial Officer | 17,303 0.007% | $26.49 | $458,356 | -1.13% | ||
2024-11-25 | Sale | Chief Financial Officer | 101,993 0.046% | $29.62 | $3.02M | -1.13% | ||
2024-11-19 | Sale | Chief Commercial Officer | 7,500 0.0032% | $22.00 | $165,000 | -0.46% | ||
2024-11-18 | Sale | Chief Operating Officer | 58,750 0.027% | $21.04 | $1.24M | +4.06% | ||
2024-11-18 | Sale | PAO | 472 0.0002% | $19.42 | $9,166 | +12.77% | ||
2024-11-14 | director | 1,000 0.0006% | $24.50 | $24,500 | -21.14% | |||
2024-11-13 | Sale | director | 40,000 0.0205% | $29.99 | $1.2M | +11.78% | ||
2024-11-13 | Sale | Chief Financial Officer | 142,886 0.073% | $29.93 | $4.28M | +11.78% | ||
2024-11-12 | Sale | Chief Legal Officer | 2,338 0.0011% | $26.46 | $61,863 | +15.27% | ||
2024-11-12 | director | 4,000 0.0019% | $26.94 | $107,760 | +15.27% |
WELLS DAVID B | director | 156036 0.0743% | $26.20 | 4 | 4 | <0.0001% |
Payne Christopher D | director | 110000 0.0524% | $26.20 | 1 | 0 | |
Okupe Oluyemi | Chief Financial Officer | 109392 0.0521% | $26.20 | 1 | 20 | +79.72% |
Dudum Andrew | Chief Executive Officer | 30710 0.0146% | $26.20 | 2 | 38 | <0.0001% |
Manuel Anja | director | 5000 0.0024% | $26.20 | 2 | 0 |
The Vanguard Group | $221.38M | 6.66 | 14.31M | +0.97% | +$2.12M | <0.01 | |
BlackRock | $168.01M | 5.06 | 10.86M | +<0.01% | +$17,156.23 | <0.01 | |
Marshall Wace | $87.25M | 2.63 | 5.64M | +7.04% | +$5.74M | 0.09 | |
Institutional Venture Management Xv Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.67M | 41.61 | |
Institutional Venture Management Xvi Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.68M | 93.86 |